Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-24 @ 6:50 PM
NCT ID:
NCT05397457
Eligibility Criteria:
Inclusion Criteria:
* Age: 20 to 75 years
* Informed Consent as documented by signature.
* Able to read and converse in chinese
* Female
* Diagnosis of breast cancer
* They completed chemotherapy no more than 2 weeks
* Treatment with neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy: anthracycline and taxane containing (paclitaxel or docetaxel) chemotherapy regimen.
* life expectancy was at least 6 months.
* Diagnosed with CIA grade 2 according to Common Terminology Criteria for Adverse Events (CTCAE)
Exclusion Criteria:
* scalp tumor or melanoma
* having any serious mental illness or history, or taking psychotropic drugs
* a medical history of dermatosis
* severe liver and kidney damage
* Pregnancy
* Take any of the following medications for 6 months prior to initiation of the study: topical minoxidil, and spironolactone, and topical calcitriol
* Receiving scalp cooling during chemotherapy
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT05397457
Study Brief:
Protocol Section:
NCT05397457